Gene · 6508
Papers3,779
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,779
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Primary Pericardial Malignant Mesothelioma:Report of a Case]. | Kyobu Geka | 2022 | 36299163 | PubTator, text mining | PubMed |
| Actualities in the Morphology and Immunohistochemistry of Cutaneous and Ocular Melanoma: What Lies Ahead? A Single-Centre Study. | Biomedicines | 2022 | 36289768 | PubTator, text mining | PubMed |
| Establishment and Characterisation of Human Clear Cell Sarcoma and Malignant Melanoma Cell Lines. | Anticancer Res | 2022 | 36288876 | PubTator, text mining | PubMed |
| Potential of VEGFR2 expression as a predictive marker of PD‑1 blockade in patients with advanced NSCLC. | Oncol Rep | 2022 | 36281948 | PubTator, text mining | PubMed |
| Multimodality imaging differentiation of pancreatic neuroendocrine tumors and solid pseudopapillary tumors with a nomogram model: A large single-center study. | Front Surg | 2022 | 36277293 | PubTator, text mining | PubMed |
| The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy. | Front Oncol | 2022 | 36276142 | PubTator, text mining | PubMed |
| Case report: CD19-directed CAR-T cell therapy combined with BTK inhibitor and PD-1 antibody against secondary central nervous system lymphoma. | Front Immunol | 2022 | 36275715 | PubTator, text mining | PubMed |
| Primary Extraskeletal Ewing sarcoma of the foot with extensive skeletal and pulmonary metastasis: A rare case report. | Ann Med Surg (Lond) | 2022 | 36268294 | PubTator, text mining | PubMed |
| Pulmonary Epithelial-Myoepithelial Carcinoma. | J Oncol | 2022 | 36268279 | PubTator, text mining | PubMed |
| Pure extracellular mucin-producing (colloid) myoepithelioma of the parotid gland. | Pathol Res Pract | 2022 | 36257234 | PubTator, text mining | PubMed |
| Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies. | Int J Mol Sci | 2022 | 36232795 | PubTator, text mining | PubMed |
| Primary Hepatic Sarcomatoid Carcinoma Presenting with Dysphagia: A Rare Presentation. | J Coll Physicians Surg Pak | 2022 | 36210681 | PubTator, text mining | PubMed |
| Combination immunotherapy in a patient with hemodialysis therapy and metachronous bilateral clear cell renal cell carcinoma: Case report and literature review. | Urol Case Rep | 2022 | 36204593 | PubTator, text mining | PubMed |
| Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma. | PLoS One | 2022 | 36201479 | PubTator, text mining | PubMed |
| Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade. | Int J Clin Oncol | 2022 | 36197545 | PubTator, text mining | PubMed |
| Primary and metastatic squamous cell carcinoma of the thyroid gland: Two case reports. | Open Life Sci | 2022 | 36185404 | PubTator, text mining | PubMed |
| Endometrial carcinoma with diffuse melanocytic differentiation: Clinicopathological and molecular analysis of a case with literature review and focus on differential diagnosis. | Pathol Res Pract | 2022 | 36174440 | PubTator, text mining | PubMed |
| Importance of biopsy site selection for peritoneal regression grading score (PRGS) in peritoneal metastasis treated with repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC). | Pleura Peritoneum | 2022 | 36159216 | PubTator, text mining | PubMed |
| Ovarian mucinous tumor with mural nodules of anaplastic carcinoma: Three case reports. | World J Clin Cases | 2022 | 36158006 | PubTator, text mining | PubMed |
| [Metastasis of medullary thyroid carcinoma to the endometrium: A case report and review of the literature]. | Rev Esp Patol | 2022 | 36154731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6508/papers?page=18